High-flux hemodialysis impacts hemodialysis patients by reducing serum FGF-23 level and controlling vascular calcification

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006249

Enrollment

Unknown

Registered

2015-04-14

Start date

2013-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease 5,Maintenance hemodialysis

Interventions

high-flux hemodialysis group: high-flux hemodialysis

low-flow hemodialysis group:low-flow hemodialysis

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: To be aged 18-70 years, previously treated with hemodialysis for at least 3 months which was performed 4 hours at a time and 3 times a week, dry weight was relatively stable, arteriovenous fistula was constructed for hemodialysis, blood flow rate >=200ml/min.

Exclusion criteria

Exclusion criteria: Patients with the diagnosis of severe infection with three months and liver disease and previously treated with hemodiafiltration, hemofiltration or peritoneal dialysis were excluded from the study.

Design outcomes

Primary

Measure	Time frame
FGF-23;AACs;	—

Secondary

Measure	Time frame
calcium;phosphorus;PTH;AKP;	—

Countries

China

Contacts

Public ContactNing JIan Ping

ningjp632@163.com+86 13637316609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026